Scientists to present new findings on gene therapy at Neuroscience 2019

Gene therapy shows promise as a way to treat and cure presently incurable neurological diseases, including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS).

Hear leading scientists announce their new findings at Neuroscience 2019, the world's largest source of emerging news and cutting-edge research on the brain and nervous system.

Watch a press conference on gene therapy Oct. 20, 2019, 1 p.m. CDT via live stream in our online press room or attend the conference in Chicago. Credentialed media receive complimentary registration to Neuroscience 2019 and access to online and on-site press rooms, top neuroscientists, embargoed press materials, and special events, providing a rich collection of news and feature possibilities.

Gene Therapy: Curing the Incurable
Sunday, October 20, 1 p.m. - 2 p.m. CDT

Gene therapy shows promise as a way to prevent, treat, and reverse neurological disorders that are presently incurable, such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS).

Gene therapy is a cutting-edge technique that uses viruses to alter the genetic code of cells, including repairing a mutated gene, silencing a disease-causing gene, or inserting a disease-fighting gene. Researchers will discuss successes in using gene therapy to restore lost functions in animal models of neurological diseases, as well as technique advancements that may improve future treatments.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
UAB team develops a combined score to predict cancer treatment success